Literature DB >> 26304988

Kupffer Cells Support Hepatitis B Virus-Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen-TLR2 Interactions in Mice.

Min Li1, Rui Sun2, Long Xu3, Wenwei Yin3, Yongyan Chen3, Xiaodong Zheng3, Zhexiong Lian4, Haiming Wei4, Zhigang Tian5.   

Abstract

Hepatitis B virus (HBV) persistence is a fundamental process in chronic HBV infection and a key factor in all related liver diseases; however, the mechanisms have yet to be elucidated. We studied the role of TLR2 in HBV persistence using a well-established HBV-carrier mouse model generated by hydrodynamically injecting a phospho-adeno-associated virus/HBV1.2 plasmid into mice. We found that a genetic deficiency in TLR2 improves HBV elimination, whereas activating TLR2 led to more stable HBV persistence, suggesting that TLR2 activation is critical in HBV persistence. Furthermore, we noted that TLR2 activation could inhibit CD8(+) T cell function, causing the exhaustion phenotype in HBV-carrier mice, because TLR2 deficiency might rescue CD8(+) T cell function in a cellular adoptive experiment. TLR2 expression on Kupffer cells (KCs) was upregulated in HBV-carrier mice, which accounts for HBV persistence, because the difference in anti-HBV immunity between HBV-carrier wild-type and Tlr2(-/-) mice did not exist after KC depletion. In addition, similar to TLR2 deficiency, after KC depletion, CD8(+) T cells were more efficiently activated in HBV-carrier mice, leading to rapid HBV elimination. KCs produced more IL-10 upon TLR2 activation in response to direct hepatitis B core Ag stimulation, and the elevated IL-10 inhibited CD8(+) T cell function in HBV-carrier mice, because IL-10 deficiency or anti-IL-10R treatment resulted in CD8(+) T cells with stronger antiviral function. In conclusion, KCs support liver tolerance by inducing anti-HBV CD8(+) T cell exhaustion via IL-10 production after TLR2 activation by hepatitis B core Ag stimulation.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26304988     DOI: 10.4049/jimmunol.1500839

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Liver macrophages in tissue homeostasis and disease.

Authors:  Oliver Krenkel; Frank Tacke
Journal:  Nat Rev Immunol       Date:  2017-03-20       Impact factor: 53.106

Review 2.  Mechanisms of Hepatitis B Virus Persistence.

Authors:  Kuen-Nan Tsai; Cheng-Fu Kuo; Jing-Hsiung James Ou
Journal:  Trends Microbiol       Date:  2017-08-16       Impact factor: 17.079

Review 3.  Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.

Authors:  Aleksei Suslov; Stefan Wieland; Stephan Menne
Journal:  Curr Opin Virol       Date:  2018-02-20       Impact factor: 7.090

Review 4.  Immunomodulation in hepatocellular cancer.

Authors:  Sunyoung Lee; Matthew Loecher; Renuka Iyer
Journal:  J Gastrointest Oncol       Date:  2018-02

5.  Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse Model.

Authors:  Shi Zou; Yanqin Du; Shunmei Huang; Shuilin Sun; Dongliang Yang; Jun Wu; Mingfa Chen; Xiaoli Yang; Sumeng Li; Yingshan Chen; Meihong Han; Jia Li; Qing Yu; Elisabeth Littwitz-Salomon; Hongming Huang; Mirko Trilling; Shi Liu; Rongjuan Pei; Jia Liu; Baoju Wang; Xin Zheng; Mengji Lu; Ulf Dittmer
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

Review 6.  Mesenchymal stem cells-based therapy in liver diseases.

Authors:  Heng-Tong Han; Wei-Lin Jin; Xun Li
Journal:  Mol Biomed       Date:  2022-07-27

Review 7.  Intrahepatic regulation of antiviral T cell responses at initial stages of viral infection.

Authors:  Yuejin Liang; Zakari Kwota; Jiaren Sun
Journal:  Int Immunopharmacol       Date:  2016-07-25       Impact factor: 4.932

Review 8.  The cGAS-STING Pathway: Novel Perspectives in Liver Diseases.

Authors:  Dongwei Xu; Yizhu Tian; Qiang Xia; Bibo Ke
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 8.786

Review 9.  Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance.

Authors:  Sheng-Han Wang; Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

Review 10.  Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output.

Authors:  Maria Fernanda Pascutti; Martje N Erkelens; Martijn A Nolte
Journal:  Front Immunol       Date:  2016-09-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.